rs894221

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000880.4(IL7):​c.361-295C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.316 in 151,906 control chromosomes in the GnomAD database, including 8,416 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 8416 hom., cov: 32)

Consequence

IL7
NM_000880.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.602

Publications

12 publications found
Variant links:
Genes affected
IL7 (HGNC:6023): (interleukin 7) The protein encoded by this gene is a cytokine important for B and T cell development. This cytokine and the hepatocyte growth factor (HGF) form a heterodimer that functions as a pre-pro-B cell growth-stimulating factor. IL7 is found to be a cofactor for V(D)J rearrangement of the T cell receptor beta (TCRB) during early T cell development. This cytokine can be produced locally by intestinal epithelial and epithelial goblet cells, and may serve as a regulatory factor for intestinal mucosal lymphocytes. IL7 plays an essential role in lymphoid cell survival, and in the maintenance of naive and memory T cells. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their presence in normal tissues has not been confirmed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can be a potent inducer of proinflammatory cytokines and chemokines which may defend against the infection, but may also mediate destructive lung injury. Elevated serum IL7 levels, together with several other circulating cytokines and chemokines, has been found to be associated with the severity of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Jul 2020]
IL7 Gene-Disease associations (from GenCC):
  • epidermodysplasia verruciformis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • epidermodysplasia verruciformis, susceptibility to, 5
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.46 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000880.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL7
NM_000880.4
MANE Select
c.361-295C>G
intron
N/ANP_000871.1
IL7
NM_001199887.2
c.360+1682C>G
intron
N/ANP_001186816.1
IL7
NM_001199886.2
c.229-295C>G
intron
N/ANP_001186815.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL7
ENST00000263851.9
TSL:1 MANE Select
c.361-295C>G
intron
N/AENSP00000263851.4
IL7
ENST00000518982.5
TSL:1
n.*348-295C>G
intron
N/AENSP00000430272.1
IL7
ENST00000520317.1
TSL:1
n.*191-295C>G
intron
N/AENSP00000427800.1

Frequencies

GnomAD3 genomes
AF:
0.315
AC:
47872
AN:
151788
Hom.:
8399
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.466
Gnomad AMI
AF:
0.220
Gnomad AMR
AF:
0.252
Gnomad ASJ
AF:
0.440
Gnomad EAS
AF:
0.0941
Gnomad SAS
AF:
0.237
Gnomad FIN
AF:
0.262
Gnomad MID
AF:
0.456
Gnomad NFE
AF:
0.263
Gnomad OTH
AF:
0.336
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.316
AC:
47930
AN:
151906
Hom.:
8416
Cov.:
32
AF XY:
0.313
AC XY:
23272
AN XY:
74248
show subpopulations
African (AFR)
AF:
0.466
AC:
19303
AN:
41436
American (AMR)
AF:
0.251
AC:
3837
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.440
AC:
1524
AN:
3460
East Asian (EAS)
AF:
0.0941
AC:
487
AN:
5176
South Asian (SAS)
AF:
0.236
AC:
1138
AN:
4818
European-Finnish (FIN)
AF:
0.262
AC:
2769
AN:
10570
Middle Eastern (MID)
AF:
0.459
AC:
135
AN:
294
European-Non Finnish (NFE)
AF:
0.263
AC:
17828
AN:
67872
Other (OTH)
AF:
0.336
AC:
708
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1595
3189
4784
6378
7973
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.149
Hom.:
246
Bravo
AF:
0.318
Asia WGS
AF:
0.206
AC:
716
AN:
3470

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.63
DANN
Benign
0.78
PhyloP100
-0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs894221; hg19: chr8-79649057; COSMIC: COSV55678437; API